Related Experiment Videos
99mTc Tetrofosmin imaging in breast tumours
C Markopoulos1, F Sampalis, C Zerva
1B'Propedeutic Department of Surgery, Medical School-University of Athens, Greece.
European Journal of Gynaecological Oncology
|June 4, 1998
Summary
99mTc Tetrofosmin imaging shows high accuracy in detecting malignant breast tumors. This nuclear medicine technique offers a promising role in breast cancer diagnosis, with excellent sensitivity and specificity.
Area of Science:
- Nuclear Medicine
- Oncology
- Radiology
Background:
- Palpable breast lumps require accurate diagnostic methods.
- Early detection of malignant breast tumors is crucial for effective treatment.
- Evaluating novel imaging agents for breast cancer diagnosis is ongoing.
Purpose of the Study:
- To assess the efficacy of 99mTc Tetrofosmin imaging for detecting malignant breast tumors.
- To determine the sensitivity, specificity, and predictive values of this imaging technique.
Main Methods:
- Eighty-five women with palpable breast lumps underwent 99mTc Tetrofosmin imaging prior to surgery.
- Intravenous injection of 99mTc Tetrofosmin followed by planar and dynamic imaging.
- Comparison of count rates in suspicious areas with normal tissue and myocardial counts.
Main Results:
- 77 out of 85 scan results (90.6%) agreed with histological findings.
- The imaging demonstrated a sensitivity of 90.32% and specificity of 91.30%.
- Positive predictive value was high at 96.55%, with six false negatives and two false positives.
Conclusions:
- 99mTc Tetrofosmin breast scanning is a valuable tool for detecting breast malignancies.
- The imaging technique exhibits high diagnostic performance in identifying cancerous breast lesions.
- This method may significantly contribute to the diagnostic workup of breast cancer.